JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2020-05-20 ms8486473624116251

审稿速度:1.0
经验分享：第一篇
3月25号投稿，4月30号小修，五一节后返修，18号接受
第二篇
4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受

115 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-08-13 静心坚持

偏重的研究方向：药理 ; 毒理
经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？

43 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2020-05-14 ms2466276523160074

审稿速度:2.0
经验分享：3月21日投稿，4月底大修。
5月12号修回直接接收。
jafc是我一度的dream paper，研究生结束前能中实在开心。
疫情原因回不了学校，就在这里写致谢吧。
过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。
感谢两位硕导，与我的贵人。
祝jafc越办越好。
btw……这因子能不能涨涨…………略低

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-12-28 小动量

所有作者在文章接收之后都会接收到邮件吗？

37 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-08-06 1212ba38m22暂无昵称

特别好的交流和分享

53 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-06-17 LSL6913

请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-12-29 桑晒麦拉

期刊可以有几个通讯作者/第一作者？

34 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-12-29 发发发发

好了，梦想成真了，果断被拒，真是新年悲剧

86 0

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-12-26 发发发发

今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了

42 0

[GetPortalCommentsPageByObjectIdResponse(id=860789, encodeId=f7be860e897f, content=审稿速度:1.0 经验分享：第一篇 3月25号投稿，4月30号小修，五一节后返修，18号接受 第二篇 4月14号投稿，5月8号大修，5月13号返修，5月15号小修，当天返修，16号接受 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=747c5414139, createdName=ms8486473624116251, createdTime=Wed May 20 23:15:40 CST 2020, time=2020-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007542, encodeId=0e79100e5428c, content=偏重的研究方向：药理 ; 毒理 经验分享：请问为什么我投稿的时候没有让填所有作者的邮件信息呢？是我投的方式不对不？我投稿成功后也没有收到投稿成功的信息，不知道大家有没有遇到过这种情况呢？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/25QibHgaz4CIUo1xBXNc5HexSXpRzoSEVPYgDNsHjBG02VNcdaJGb72AMfO5CxFOgY3eicd1C9zpnATxYpHicD4wA/132, createdBy=ce322479135, createdName=静心坚持, createdTime=Fri Aug 13 10:24:49 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860560, encodeId=658486056046, content=审稿速度:2.0 经验分享：3月21日投稿，4月底大修。 5月12号修回直接接收。 jafc是我一度的dream paper，研究生结束前能中实在开心。 疫情原因回不了学校，就在这里写致谢吧。 过去一年间，我痛定思痛从分子脱坑，学着做组学。经历各种坎坷，然而终究是找到了方向。 感谢两位硕导，与我的贵人。 祝jafc越办越好。 btw……这因子能不能涨涨…………略低 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=318b5414073, createdName=ms2466276523160074, createdTime=Thu May 14 18:06:16 CST 2020, time=2020-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092326, encodeId=152c109232638, content=所有作者在文章接收之后都会接收到邮件吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1005549, encodeId=872110055490f, content=特别好的交流和分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5b9d2233692, createdName=1212ba38m22暂无昵称, createdTime=Fri Aug 06 08:54:13 CST 2021, time=2021-08-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974374, encodeId=aed09e43746c, content=请问各位，杂志要求的Written statement on the manuscript’s significance，需要写Three bullet points，请问每一点大概写几句话呢？类似highlights吗？谢谢！！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6212102439, createdName=LSL6913, createdTime=Thu Jun 17 13:53:27 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092325, encodeId=c94d1092325b5, content=期刊可以有几个通讯作者/第一作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=34, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Wed Dec 29 14:52:49 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085537, encodeId=9da8108553eb2, content=好了，梦想成真了，果断被拒，真是新年悲剧, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Wed Dec 29 19:11:29 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084515, encodeId=bc221084515fd, content=今天刚刚投稿，持续更新自己的过程吧，希望别上来就给refuse了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=34165712786, createdName=发发发发, createdTime=Sun Dec 26 23:03:07 CST 2021, time=2021-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077666, encodeId=e27210e766602, content=请问有这个期刊的投稿要求吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c5b56388228, createdName=ms5000000280054892, createdTime=Tue Dec 07 09:45:22 CST 2021, time=2021-12-07, status=1, ipAttribution=)]

2021-12-07 ms5000000280054892

请问有这个期刊的投稿要求吗？

29 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务